Clinical Trials Browser

Phase 2 × Recruiting × Neurotoxicity Syndromes × Clear all

NCT06551051 2024-09-19

ADC-induced Neurotoxicity Treated With Duloxetine

Phase 2 Recruiting

Neurotoxicity Syndromes